CAIRO, February 6, 2017—Kantar Health, a leading global healthcare consulting and market research firm, today announced that Neeraj Behl has been named General Manager, MENA, leading Kantar Health’s innovative marketing insights business in the quickly growing Middle East and North Africa region.
“MENA is a region that is changing quickly and offers a lot of potential for Kantar Health,” said Graeme Jacombs, Managing Director – Asia Pacific, Middle East, Africa, Kantar Health. “With his breadth of research knowledge and deep understanding of the MENA region, I’m delighted that Neeraj is joining us to lead our continuing growth in the region.”
Behl has considerable experience in the Middle East and North Africa, having spent over 10 years based in Dubai and Cairo. He joins Kantar Health from AMRB, a fellow Kantar company, where he was most recently General Manager, North Africa. Behl has successfully partnered with a wide range of clients in the region while managing business responsibilities for Research International (now part of TNS), Millward Brown, and AMRB. He has an M.B.A. in Marketing.
“I’m quite excited and proud to be part of the Kantar Health family,” Behl said. “It’s a group of amazingly capable people, knit together by the passion of enabling their clients to bring the best of healthcare to patients.”
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 600+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. Kantar Health is part of Kantar, the data investment management division of WPP. For more information, please visit www.kantarhealth.com.